Literature DB >> 17328914

Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.

Christiane Reitz1, Bindu Patel, Ming-Xin Tang, Jennifer Manly, Richard Mayeux, Jose A Luchsinger.   

Abstract

BACKGROUND: Vascular risk factors increase the risk of Alzheimer's disease (AD). The mechanisms for these associations are unclear, and may be due to misdiagnosis of a vascular dementia syndrome as AD.
OBJECTIVE: To examine differences in neuropsychological profile among persons diagnosed clinically with AD with and without vascular risk factors or stroke.
METHODS: Community based cohort study. Individual and composite scores of neuropsychological tests at the time of clinical diagnosis of incident AD were compared among 243 persons with and without vascular risk factors or stroke.
RESULTS: Among subjects with incident AD, diabetes was associated with lower performance in Delayed Recall of the Selective Reminding Test (SRT), while persons diagnosed with hypertension scored lower in consistent long term recall (CLTR) of the SRT and current smokers scored lower in Category Fluency. None of the risk factors was associated with differences in composite scores in memory, abstract/visuospatial or language domain, nor was the number of risk factors per person. Persons with stroke had a higher delayed recall score at the time of AD diagnosis.
CONCLUSION: The presence of vascular risk factors among persons with clinically diagnosed AD was associated with subtle differences in neuropsychological profile at the time of diagnosis. This study needs to be replicated in samples with brain imaging, a comprehensive executive abilities battery, and pathological diagnosis of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328914      PMCID: PMC2725022          DOI: 10.1016/j.jns.2007.01.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  44 in total

1.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

2.  Equivalence of the Color Trails Test and Trail Making Test in nonnative English-speakers.

Authors:  A T Dugbartey; B D Townes; R K Mahurin
Journal:  Arch Clin Neuropsychol       Date:  2000-07       Impact factor: 2.813

Review 3.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

4.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

5.  Understanding the pathology of vascular cognitive impairment.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2004-12-08       Impact factor: 3.181

6.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

7.  Poststroke dementia : clinical features and risk factors.

Authors:  R Barba; S Martínez-Espinosa; E Rodríguez-García; M Pondal; J Vivancos; T Del Ser
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

8.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

Authors:  H B Posner; M-X Tang; J Luchsinger; R Lantigua; Y Stern; R Mayeux
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

9.  Plasma homocysteine levels and risk of Alzheimer disease.

Authors:  J A Luchsinger; M-X Tang; S Shea; J Miller; R Green; R Mayeux
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

10.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Authors:  Wesley Farris; Stefan Mansourian; Yang Chang; Loren Lindsley; Elizabeth A Eckman; Matthew P Frosch; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe; Suzanne Guenette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

View more
  9 in total

1.  Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Authors:  Mary Sano; Rema Raman; Jennifer Emond; Ronald G Thomas; Ronald Petersen; Lon S Schneider; Paul S Aisen
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

2.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

3.  A summary risk score for the prediction of Alzheimer disease in elderly persons.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-07

4.  The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Authors:  Melissa Lamar; David J Libon; Angela V Ashley; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  J Int Neuropsychol Soc       Date:  2009-10-19       Impact factor: 2.892

5.  High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey.

Authors:  Thomas Olabode Obisesan; Odunayo Abiodun Obisesan; Sayyida Martins; Laila Alamgir; Vernon Bond; Celia Maxwell; Richard Frank Gillum
Journal:  J Am Geriatr Soc       Date:  2008-01-04       Impact factor: 5.562

Review 6.  Hypertension and cognitive function.

Authors:  Thomas Olabode Obisesan
Journal:  Clin Geriatr Med       Date:  2009-05       Impact factor: 3.076

7.  Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups.

Authors:  Julianna Bauman; Laura E Gibbons; Mackenzie Moore; Shubhabrata Mukherjee; Susan M McCurry; Wayne McCormick; James D Bowen; Emily Trittschuh; Maria Glymour; Jesse Mez; Andrew J Saykin; Kristen Dams-O'Conner; David A Bennett; Eric B Larson; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Association of dyslipidaemia with Alzheimer's disease in a cohort of postmenopausal women.

Authors:  Ning Li; Xiaoying Xu; Shuai Mao; Ye Jiang; Yadong Hu; Ruowei Xing; Yajing Chen; Junxing Ye; Li Ling; Xianshang Zeng; Guowei Han
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 9.  Brain arteriolosclerosis.

Authors:  Brittney L Blevins; Harry V Vinters; Seth Love; Donna M Wilcock; Lea T Grinberg; Julie A Schneider; Rajesh N Kalaria; Yuriko Katsumata; Brian T Gold; Danny J J Wang; Samantha J Ma; Lincoln M P Shade; David W Fardo; Anika M S Hartz; Gregory A Jicha; Karin B Nelson; Shino D Magaki; Frederick A Schmitt; Merilee A Teylan; Eseosa T Ighodaro; Panhavuth Phe; Erin L Abner; Matthew D Cykowski; Linda J Van Eldik; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2020-10-24       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.